This Program Project application will Investigate the molecular mechanisms of prostate cancer initiation. The proposed studies will be pursued by a highly-integrated Interdisciplinary team of investigators who have substantial track records in prostate cancer research, as well as in collaborative interactions with each other. Our proposal has a central focus on the role of NKX3.1, a key regulator of gene expression programs in the prostate epithelium whose expression is down-regulated during prostate cancer initiation. Recent studies by members of our research team have shown that Nkx3.1 is a marker for a prostate epithelial stem cell population that is a cell type of origin for prostate cancer in mice, and that Nkx3.1 plays a role in stem cell maintenance. Furthermore, NKX3.1 participates in the earliest molecular events involved in the response to DNA damage, while NKX3.1 loss predisposes to increased oxidative damage, decreased survival after DNA damage, and cellular senescence. Thus, analysis of NKX3.1 function in prostate tumorigenesis represents an excellent model for investigating cancer initiation. We will pursue three interrelated projects that will investigate the molecular mechanisms of prostate cancer initiation using genetically-engineered mouse and cell culture models, together with essential validation using human xenografts and clinical specimens. Project 1 (Shen) will investigate the potential cell type(s) of origin for prostate cancer in mouse models, and will determine whether these cells of origin can give rise to tumor-initiating cells. Project 2 (Abate-Shen) will analyze the roles for Nkx3.1 in prostate epithelial specification and cellular senescence, and will identify Nkx3.1 target genes through genome-wide analyses coupled with functional validation in mouse and human prostate. Project 3 (Gelmann) will investigate the role of Nkx3.1 in the DNA damage response in cell culture and mouse models. These Projects will be assisted by Core A (Cordon-Cardo), which will provide pathology support for the Projects and will examine the incidence and co-localization of known molecular events in prostate cancer initiation, as well as by Core B (Shen), which will provide administrative, bioinformatic, and biostatistical support for the overall Program.

Public Health Relevance

The earliest events that increase susceptibility of the aging male represent critical targets in the battle against prostate cancer. Thus, therapeutic intervention at these gatekeeper events should greatly impair the development and progression of clinical prostate cancer. Detailed understanding of the molecular mechanisms of cancer initiation will provide key insights into chemoprevention and therapeutic targets at the level of individual proteins and signaling pathways, as well as stem cell populations that represent the heart of malignancy.

National Institute of Health (NIH)
Research Program Projects (P01)
Project #
Application #
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Mietz, Judy
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Chen, James C; Alvarez, Mariano J; Talos, Flaminia et al. (2014) Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks. Cell 159:402-14
Aytes, Alvaro; Mitrofanova, Antonina; Lefebvre, Celine et al. (2014) Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. Cancer Cell 25:638-51
Wang, Zhu A; Toivanen, Roxanne; Bergren, Sarah K et al. (2014) Luminal cells are favored as the cell of origin for prostate cancer. Cell Rep 8:1339-46
Chua, Chee Wai; Shibata, Maho; Lei, Ming et al. (2014) Single luminal epithelial progenitors can generate prostate organoids in culture. Nat Cell Biol 16:951-61, 1-4
Bowen, Cai; Ju, Jeong-Ho; Lee, Ji-Hoon et al. (2013) Functional activation of ATM by the prostate cancer suppressor NKX3.1. Cell Rep 4:516-29
Irshad, Shazia; Bansal, Mukesh; Castillo-Martin, Mireia et al. (2013) A molecular signature predictive of indolent prostate cancer. Sci Transl Med 5:202ra122
Aytes, Alvaro; Mitrofanova, Antonina; Kinkade, Carolyn Waugh et al. (2013) ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer. Proc Natl Acad Sci U S A 110:E3506-15
Jin, Feng; Irshad, Shazia; Yu, Wei et al. (2013) ERK and AKT signaling drive MED1 overexpression in prostate cancer in association with elevated proliferation and tumorigenicity. Mol Cancer Res 11:736-47
Wang, Zhu A; Mitrofanova, Antonina; Bergren, Sarah K et al. (2013) Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol 15:274-83
Shen, Michael M (2013) Chromoplexy: a new category of complex rearrangements in the cancer genome. Cancer Cell 23:567-9

Showing the most recent 10 out of 11 publications